Idi na sadržaj

Onkologija

Liječenje neutropenije

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. (otvara se novi prozor)

Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Donnelly JP, Kearney N, Lyman GH, Pettengell R, Tjan-Heijnen VC, Walewski J, Weber DC, Zielinski C; European Organisation for Research and Treatment of Cancer.

Izvor‎: Eur J Cancer 2011;47(1):8-32.

Indeks‎: PubMed 21095116

DOI‎: 10.1016/j.ejca.2010.10.013

https://www.ncbi.nlm.nih.gov/pubmed/21095116 (otvara se novi prozor)

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. (otvara se novi prozor)

Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR; Infectious Diseases Society of America.

Izvor‎: Clin Infect Dis 2011;52(4):427-31.

Indeks‎: PubMed 21205990

DOI‎: 10.1093/cid/ciq147

https://www.ncbi.nlm.nih.gov/pubmed/21205990 (otvara se novi prozor)

High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah's Witnesses patients: a feasible option in the age of hematopoietic growth factors. (otvara se novi prozor)

Perol L, Grignano E, Contejean A, Gastaud L, Legoff M, Franchi P, Deau-Fischer B, Willems L, Bouscary D, Tamburini J

Izvor‎: Leuk Lymphoma. 2019;60(9):2324-7.

Indeks‎: PubMed 30773115

DOI‎: 10.1080/10428194.2019.1577414

https://www.ncbi.nlm.nih.gov/pubmed/30773115 (otvara se novi prozor)

Recommendations for the use of WBC growth factors: American Society of Clinical Oncology Clinical Practice Guideline Update. (otvara se novi prozor)

Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, Goldberg JM, Khatcheressian JL, Leighl NB, Perkins CL, Somlo G, Wade JL, Wozniak AJ, Armitage JO; American Society of Clinical Oncology.

Izvor‎: J Clin Oncol 2015;33(28):3199-212.

Indeks‎: PubMed 26169616

DOI‎: 10.1200/JCO.2015.62.3488

https://www.ncbi.nlm.nih.gov/pubmed/26169616 (otvara se novi prozor)